drugset / Trial / NCT07499999
Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
Phase 2
Not yet recruiting
140 enrolled
Dana-Farber Cancer Institute
Breast Cancer Research Foundation · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
The goal of this research study is to evaluate the efficacy and safety of low-dose exemestane versus low-dose tamoxifen in post-menopausal women at high risk for breast cancer. The names of the study drugs involved in this study are: * Exemestane (a type of steroidal aromatase inhibitor) * Tamoxifen (a type of selective estrogen receptor modulator)
Timeline
- Start
- 2026-09-09
- Primary completion
- 2027-08-31
- Completion
- 2028-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exemestane | Small molecule | — | Oral |
| Subject | Tamoxifen | Small molecule | — | Oral |